Düsseldorf, Nordrhein-Westfalen, Germany IKB appeared to be the Corporate Investor, which was created in 1924. The main department of described Corporate Investor is located in the Du00fcsseldorf. The company was established in Europe in Germany.
The typical case for the fund is to invest in rounds with 5-6 participants. Despite the IKB, startups are often financed by Techno Venture Management, AlpInvest Partners, Qiagen. The meaningful sponsors for the fund in investment in the same round are Techno Venture Management, KBL Healthcare Ventures, AlpInvest Partners. In the next rounds fund is usually obtained by Techno Venture Management, AlpInvest Partners, Vontobel.
Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. For fund there is a match between the location of its establishment and the land of its numerous investments - Germany. Among the most successful fund investment fields, there are Manufacturing, Biotechnology. Among the most popular portfolio startups of the fund, we may highlight Cardion, EpiCept Corporation, EpiCept Corporation.
The higher amount of exits for fund were in 2012. The fund is constantly included in less than 2 deals per year. This IKB works on 38 percentage points more the average amount of lead investments comparing to the other organizations. The usual things for fund are deals in the range of 10 - 50 millions dollars. The important activity for fund was in 2000.
Related Funds
| Fund Name | Location |
| Al Hilal Bank | Abu Dhabi, Abu Dhabi Emirate, United Arab Emirates |
| Alyeska Venture Management | Alaska, Anchorage, United States |
| Ambrosia Investments | Luxembourg, Luxembourg |
| Beijing Yatai Ruilong Shangmao | Beijing, China, Pinggu |
| BuySell Technologies | Japan, Yamanashi, Yamanashi Prefecture |
| Caring Entrepreneurship Fund | Belgium, Brussels, Brussels Hoofdstedelijk Gewest |
| CI Capital | Egypt, Texas, United States |
| Debaeque | Barcelona, Catalonia, Spain |
| FISCO Capitals | Japan, Osaka, Osaka Prefecture |
| FOREIS dotation fund | - |
| Human Genome Sciences | Maryland, Rockville, United States |
| IoT UK | - |
| J&T Finance Group | District of Zvolen, Region of Banská Bystrica, Slovakia |
| LGL Capital Pty Ltd | - |
| Notre Dame Pit Road Fund | Indiana, South Bend, United States |
| Pacific Capital Group | Luxembourg, Luxembourg |
| Symcon | Charlotte, North Carolina, United States |
| Weinberg Capital Partners | France, Ile-de-France, Paris |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Ingenium Pharmaceuticals AG | $59M | 01 Oct 2000 | Germany, Bavaria, Germany | ||
EpiCept Corporation | $4M | 01 Jan 2000 | New Jersey, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Ingenium Pharmaceuticals AG | $59M | 01 Oct 2000 | Germany, Bavaria, Germany | ||
EpiCept Corporation | $4M | 01 Jan 2000 | New Jersey, United States |
